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Dear Editor,
Posttraumatic stress disorder (PTSD) is a psychiatric disorder 
that develops after a traumatic event, characterized by specific 
symptoms such as re-experiencing, avoidance, blunting, hyperarousal 
symptoms, and non-specific symptoms such as nightmares, sleep 
disturbances, and impaired functioning. Sleep disorders are a very 
significant problem in PTSD patients and are generally resistant to 
treatment. Impaired sleep quality has been shown to be associated 
with increased PTSD symptom severity and suicidal ideation1. 
Although medications and psychotherapy are at the top of the list for 
the treatment of PTSD, repetitive Transcranial magnetic stimulation 
(rTMS) has recently emerged as an important treatment option in 
treatment-resistant PTSD cases2. In this article, treatment of insomnia 
with rTMS in a patient with PTSD is described. 
A 45-year-old male patient was followed up for 20 years with a 
diagnosis of PTSD. The patient presented with a three-month history 
of insomnia while in remission, with treatment of lithium 1200 mg/d 
and sertraline 100 mg/d. No pathology was found when this patient 
was studied with diagnostic tests such as an MRI of the brain and 
an EEG applied for the exclusion of organicity, and the laboratory 
findings of the patient were within normal limits. No pathology 
was found in the patient’s internal medicine, neurology, and chest 
consultations. The patient underwent a one-night polysomnographic 
measure (PSG). Sleep-apnea syndrome, snoring, and periodic 
leg-movement disturbances were not observed during PSG. The 
PSG findings supported insomnia consistent with the patient’s 
complaints. Although the patient was treated with agomelatine, 
ramelteon, clonazepam, lorazepam, trazodone, herbal preparations, 
and quetiapine in sufficient doses and time, his complaints did not 
regress. It was thought that the patient would benefit from rTMS, 
and it was decided that rTMS should be applied. 
The patient received 1500 high-frequency (10Hz) repetitive 
sessions with 40 pulses (four seconds each) on his left dorsolateral 
prefrontal cortex for 26-second pulse intervals (20 consecutive 
sessions/30 minutes each weekday) at 120% of motor threshold 
for four weeks. rTMS was performed using the Dantec magnetic 
stimulator (Dantec Medical A/S, Skovlunde, Denmark) for magnetic 
stimulation, and the Dantec MC-125 circular structure coil (Dantec 
Medical A/S, Skovlunde, Denmark) with an internal diameter of 90 
mm was used as the stimulus coil. After rTMS, the patient’s CAPS 
scale “difficulty falling asleep and maintaining sleep” item decreased 
from 3 points to 0 points. The patient did not have any additional 
immediate complaints, and his complaints did not recur during the 
first and sixth month follow-up examinations.
As with all psychiatric disorders, sleep disorders are one of the 
symptoms closely related to quality of life for people who have PTSD. 
Moreover, sleep disorders are also closely related to the severity of 
PTSD. Treatment of sleep disorders is therefore very important in 
patient management. Although medical treatment and/or behavioral 
changes take the first place in the treatment of sleep disorders, our 
case should be taken into consideration, as it shows that rTMS 
treatment can be used as an alternative in treatment-resistant cases.
The effect of rTMS on the treatment of insomnia is unknown. 
However, there are two possible mechanisms. The first of these, 
noradrenaline, which has neuromodulator functions in the brain, 
also has an effect on sleep regulation3. It is possible that the 
regulation disorder that occurs in the noradrenergic system in 
the pathophysiology of PTSD is the cause of insomnia symptoms 
in our patient.1 The effect of rTMS on the noradrenergic system, 
as well as serotonin, may have been effective in relieving our 
patient’s complaints4. Another possible mechanism may be that the 
deterioration of neuroplasticity and hippocampal function, which 
is shown to be the cause of sleep disorders in PTSD patients, is 
corrected by rTMS4,5. In addition, although the findings in our case 
support PTSD-related insomnia, it should be noted that depression 
or another psychiatric cause-related insomnia may have been treated.
rTMS can be considered as an alternative treatment for possible 
treatment-resistant sleep disorders in PTSD patients. However, 
randomized blind-controlled trials with PSG are needed to evaluate 
the efficacy of rTMS on sleep disorders.
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